Beaumont Capital Management’s ESSA Pharma EPIX Stock Holding History

Beaumont Capital Management’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-28,225	Closed	-$5.39K	–	42
2025 Q3	$5.39K	Buy	+28,225	New	+$33.8K	﹤0.01%	48

Beaumont Capital Management's EPIX Position: Q4 2025 in Review

Beaumont Capital Management sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 28,225 shares — an estimated $5.39K sold.

Beaumont Capital Management first reported a position in EPIX in Q3 2025 and held it in 1 quarter. The position peaked at $5.39K in Q3 2025. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

Beaumont Capital Management reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
Beaumont Capital Management sold 28,225 ESSA Pharma shares in Q4 2025, an estimated $5.39K.
Beaumont Capital Management first reported a position in ESSA Pharma in Q3 2025 and held it in 1 quarter.
Beaumont Capital Management's ESSA Pharma position peaked at $5.39K in Q3 2025.
0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on Beaumont Capital Management's 13F filing for Q4 2025, filed 10 Feb 2026.